Insider · CIK 0001454337

PERRY MATTHEW D

Reports to the SEC for 3 companies · EMERYVILLE, CA

sec.gov

Transactions

Companies

Filings

CIK

0001454337

Forms 4 and 5

Insider transactions

39 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-14	XOMA Royalty CorpJ Other	Director	JOther	−24.1K sh	—	—	0
2026-07-14	XOMA Royalty CorpStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15.2K sh	—	—	0
2026-07-14	XOMA Royalty CorpStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,052 sh	—	—	0
2026-07-14	XOMA Royalty CorpStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,167 sh	—	—	0
2026-07-14	XOMA Royalty CorpStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,152 sh	—	—	0
2026-07-14	XOMA Royalty CorpStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,101 sh	—	—	0
2026-07-14	XOMA Royalty CorpStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,996 sh	—	—	0
2026-07-14	XOMA Royalty CorpStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−11K sh	—	—	0
2026-05-21	XOMA Royalty CorpA Award	Director	AAward	+3,586 sh	—	—	27,426
2025-05-21	XOMA Royalty CorpA Award	Director	AAward	+5,971 sh	—	—	23,840
2024-05-15	XOMA Royalty CorpA Award	Director	AAward	+6,070 sh	—	—	17,869
2023-06-26	CTI BIOPHARMA CORPU Disposition from Tender	Director	UDisposition from Tender	−43.1K sh	$9.10	−$393K	0
2023-06-26	CTI BIOPHARMA CORPStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−50K sh	—	—	0
2023-06-26	CTI BIOPHARMA CORPStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−60K sh	—	—	0
2023-06-26	CTI BIOPHARMA CORPStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−120K sh	—	—	0
2023-06-26	CTI BIOPHARMA CORPStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−80K sh	—	—	0
2023-06-26	CTI BIOPHARMA CORPStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−80K sh	—	—	0
2023-06-26	CTI BIOPHARMA CORPStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−80K sh	—	—	0
2023-05-17	XOMA Royalty CorpNon-Qualified Share Option (right to buy)A Award	Director	AAward	+11K sh	—	—	10,967
2023-04-05	CTI BIOPHARMA CORPStock Option (right to buy)A Award	Director	AAward	+80K sh	—	—	80,000
2022-05-18	XOMA Royalty CorpNon-Qualified Share Option (right to buy)A Award	Director	AAward	+8,996 sh	—	—	8,996
2022-03-09	CTI BIOPHARMA CORPStock Option (right to buy)A Award	Director	AAward	+80K sh	—	—	80,000
2021-05-19	XOMA Royalty CorpNon-Qualified Stock Option (right to buy)A Award	Director	AAward	+5,101 sh	—	—	5,101
2021-03-10	CTI BIOPHARMA CORPStock Option (right to buy)A Award	Director	AAward	+80K sh	—	—	80,000
2020-12-11	XOMA Royalty CorpP Purchase	Director	PPurchase	+200K sh	$25.00	+$5M	200,000
2020-05-20	XOMA Royalty CorpNon-Qualified Stock Option (right to buy)A Award	Director	AAward	+6,152 sh	—	—	6,152
2019-05-16	CTI BIOPHARMA CORPNon-Qualified Stock Option (Right to Buy)A Award	Director	AAward	+120K sh	—	—	120,000
2019-05-16	XOMA Royalty CorpNon-Qualified Stock Option (right to buy)A Award	Director	AAward	+8,167 sh	—	—	8,167
2018-05-17	XOMA Royalty CorpNon-Qualified Stock Option (right to buy)A Award	Director	AAward	+5,052 sh	—	—	5,052
2018-05-17	CTI BIOPHARMA CORPNon-Qualified Stock Option (Right to Buy)A Award	Director	AAward	+60K sh	—	—	60,000
2017-04-28	CTI BIOPHARMA CORPM Exercise/Conversion	Director	MExercise/Conversion	+34.7K sh	—	—	43,139
2017-04-28	CTI BIOPHARMA CORPRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−34.7K sh	—	—	0
2017-03-02	XOMA Royalty CorpA Award	Director	AAward	+11.8K sh	—	—	11,799
2017-03-02	XOMA Royalty CorpNon-Qualified Stock Option (right to buy)A Award	Director	AAward	+15.2K sh	—	—	15,222
2017-02-23	CTI BIOPHARMA CORPStock Option (Right to Buy)A Award	Director	AAward	+50K sh	—	—	50,000
2017-01-11	CTI BIOPHARMA CORPM Exercise/Conversion	Director	MExercise/Conversion	+8,403 sh	—	—	8,403
2017-01-11	CTI BIOPHARMA CORPRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−8,403 sh	—	—	0
2016-04-29	CTI BIOPHARMA CORPRestricted Stock UnitsA Award	Director	AAward	+347K sh	—	—	431,394
2016-01-11	CTI BIOPHARMA CORPRestricted Stock UnitsA Award	Director	AAward	+84K sh	—	—	84,034

Recent filings

Accepted (ET)
Jul 144
PERRY MATTHEW D0001193125-26-303721
SEC(opens sec.gov)
May 264
PERRY MATTHEW D0001214659-26-006746
SEC(opens sec.gov)
May 234
PERRY MATTHEW D0001214659-25-008321
SEC(opens sec.gov)
May 174
PERRY MATTHEW D0001214659-24-009518
SEC(opens sec.gov)
Jun 264
PERRY MATTHEW D0000899243-23-016484
SEC(opens sec.gov)
May 194
PERRY MATTHEW D0001214659-23-007563
SEC(opens sec.gov)
Apr 74
PERRY MATTHEW D0000899243-23-010977
SEC(opens sec.gov)

Companies

Address

C/O XOMA ROYALTY CORPORATION 2200 POWELL STREET, SUITE 310

EMERYVILLE, CA, 94608